Hezhen Medicine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hezhen Medicine - overview
Established
2012
Location
Hangzhou, Zhejiang, China
Primary Industry
Pharmaceuticals
About
Founded in 2012 and based in Hangzhou, China, Hangzhou Hezhen Medicine Co. , Ltd. , dba Hezhen Medicine, integrates drug discovery, process development, and formulation innovation. The company has established research platforms for new drug delivery systems and druggability evaluation, driving innovation in sustained and controlled-release technologies and novel chemical entities.
Hezhen Medicine engages in the development of innovative and generic drugs, with expertise in sustained-release formulations and synthesis process optimization. Its product portfolio focuses on immuno-oncology and liver disease therapeutics, supported by in-house R&D, technology transfer, and production capabilities. The company generates revenue from the development and commercialization of proprietary drug formulations, technology transfer, contract research services, and product sales in the biopharmaceutical sector. In November 2025, Hezhen Medicine closed Series B+ funding led by new investor Qiming Venture Partners.
Current Investors
Liyuan Venture Capital, GT Capital, Qiming Venture Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.healzentx.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Hezhen Medicine - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B | Completed | Hezhen Medicine | - | ||||||||
| Unspecified Round | Completed | Hezhen Medicine | - | ||||||||
| Series A | Completed | Hezhen Medicine | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.